Company: BIAF
Filing Date: 2025-04-11
Form Type: S-1
Source: 0001641172-25-003892
Chunk: 91

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-11
Form: S-1
Chunk 91
---
, PO Box 10085, Grand Cayman KY1-1001, Cayman Islands.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| (6) | The shares listed in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 third column consist of 312,000 shares of Common Stock issuable upon exercise of Inducement Warrants. The shares listed in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 second column included the aforementioned 312,000 shares of Common Stock issuable upon exercise of the Inducement Warrants (despite                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
 the fact that the exercise of the Inducement Warrants is subject to shareholder approval and therefore the shares of Common Stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
 issuable upon exercise of the Inducement Warrants is not deemed beneficially owned at this time), as well as 670,027 shares of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 Common Stock.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| (7) | Each of these Selling Stockholders is a designee of, and is affiliated with, WallachBeth Capital LLC. WallachBeth Capital, LLC is a registered broker dealer and has a registered address of c/o WallachBeth Capital, LLC, 1001 Yamato Road, Suite 404, Boca Raton, Florida 33431. The number of shares beneficially owned prior to this offering include shares of Common Stock issuable upon exercise of warrants received as compensation in connection with our sale of convertible bridge notes in 2021 and 2022, our initial public offering and subsequent private placement offerings, including the Advisor Warrants received as compensation for the Warrant Inducement. The number of shares listed in the third column, which are the shares to be sold in this offering, consist of the shares of Common Stock issuable upon exercise of the Advisor Warrants. WallachBeth Capital, LLC and its designees acquired the Advisor Warrants in the ordinary course of business and, at the time the Advisor Warrants were acquired, WallachBeth Capital, LLC nor its designees had any agreement or understanding, directly or indirectly, with any person to distribute such securities. |

| 42 |

<div align='center'>MARKET INFORMATION FOR SECURITIES AND DIVIDEND POLICY</div>

Market Information

Our Common Stock is currently listed on the Nasdaq
Capital Market under the symbol “BIAF.” Our Tradeable Warrants are currently listed on the